TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1163469

Group type: EXPERIMENTAL
Intervention: 12 g nitrogen diet
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 24 g nitrogen diet
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Calcium supplement of 0.9 g on the 12 g nitrogen diet
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 0.9 g nitrogen diet
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Calcium and protein intake variation
Number of subjects: 6
Study: 31076215

Group type: EXPERIMENTAL
Intervention: Benefit-Finding Therapeutic Intervention (BFT)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Standard Psychoeducation (Control)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Simplified Psychoeducation (Control)
Number of subjects: 129
Study: 28742103

Group type: EXPERIMENTAL
Intervention: Intervention group (teachers trained to educate on HIV/AIDS)
Number of subjects: 1381
Study: 25793988

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 23675796

Group type: EXPERIMENTAL
Intervention: SNAPPS group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual and customary group
Number of subjects: 38
Study: 21327728

Group type: EXPERIMENTAL
Intervention: Transtympanic steroid injections (Group A)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Oral administration of steroids (Group B)
Number of subjects: 46
Study: 19844853

Group type: EXPERIMENTAL
Intervention: New therapeutic developments in lung cancer management
Number of subjects: 0
Study: 16489524

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (very-point technique)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham laser treatment (placebo)
Number of subjects: 23
Study: 12724245

Group type: EXPERIMENTAL
Intervention: Non-directive counselling
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Psychodynamic therapy
Number of subjects: 193

Group type: COMPARATOR
Intervention: Routine primary care
Number of subjects: 193
Study: 10647539

Group type: EXPERIMENTAL
Intervention: DRINK (oral rehydration, 0.45% NaCl)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: IV (intravenous rehydration, 0.45% NaCl)
Number of subjects: 8

Group type: COMPARATOR
Intervention: CONTROL (no fluid)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: IV
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: DRINK
Number of subjects: 8

Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 8
Study: 7537488

Group type: EXPERIMENTAL
Intervention: Alfuzosin 2.5 mg tid
Number of subjects: 63

Group type: COMPARATOR
Intervention: Serenoa repens 160 mg bid
Number of subjects: 63
Study: 1963273

Group type: EXPERIMENTAL
Intervention: Pirarubicin (THP) at 55 mg/m2, Etoposide at 100 mg/m2 (days 1-3), Vincristine at 2 mg (day 1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pirarubicin (THP) at 60 mg/m2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pirarubicin (THP) at 40 mg/m2, 50 mg/m2, and 55 mg/m2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pirarubicin (THP) at 55 mg/m2
Number of subjects: 20
Study: 31380689

Group type: EXPERIMENTAL
Intervention: Individuals whose partner participated in the study
Number of subjects: 1294

Group type: COMPARATOR
Intervention: Individuals whose partner did not participate
Number of subjects: 1294

Group type: COMPARATOR
Intervention: Individuals who participated alone despite being asked to invite their partner
Number of subjects: 1294
Study: 28801880

Group type: EXPERIMENTAL
Intervention: Educational Intervention (EI)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 133
Study: 28274672

Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (LDCT) screening
Number of subjects: 1589
Study: 26978767

Group type: EXPERIMENTAL
Intervention: Single laparoscopic access
Number of subjects: 95

Group type: COMPARATOR
Intervention: Multiport laparoscopic-assisted technique
Number of subjects: 95
Study: 23706051

Group type: EXPERIMENTAL
Intervention: ITPR device with -5 mm Hg endotracheal tube pressure
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ITPR device with -9 mm Hg endotracheal tube pressure
Number of subjects: 10
Study: 21385788

Group type: EXPERIMENTAL
Intervention: Caloric restriction (25% CR)
Number of subjects: 77
Study: 19632695

Group type: EXPERIMENTAL
Intervention: Carbohydrate-restricted diet (CRD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-fat diet (LFD)
Number of subjects: 40
Study: 17374025

Group type: EXPERIMENTAL
Intervention: Dietary intervention group (IG: n=39) attending regular nutrition education sessions for 5 months
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (CG: n=36)
Number of subjects: 75
Study: 14686965

Group type: EXPERIMENTAL
Intervention: Acarbose, 150 mg/day
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 11829107

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) at a daily dose of 60 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (nCPAP)
Number of subjects: 10
Study: 9503434

Group type: EXPERIMENTAL
Intervention: Convergence Insufficiency (CI) classification
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Symptoms related to CI
Number of subjects: 620
Study: 9229882

Group type: EXPERIMENTAL
Intervention: Intravenous indomethacin 50 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2630362

Group type: EXPERIMENTAL
Intervention: Contrast Sensitivity Test (CST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electro-retinography (EOG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pattern Visual Evoked Potential (PVEP)
Number of subjects: 0
Study: 776487

Group type: EXPERIMENTAL
Intervention: Atenolol 75 mg/day, increased to a maximum of 900 mg if tolerated
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Atenolol therapy after 8 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 18
Study: 30958833

Group type: EXPERIMENTAL
Intervention: CARE4STROKE program (8-week caregiver-mediated exercise program with e-health support)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 66
Study: 28643825

Group type: EXPERIMENTAL
Intervention: Implant-supported removable partial denture with implants placed in the molar region
Number of subjects: 30

Group type: COMPARATOR
Intervention: Implant-supported removable partial denture with implants placed in the pre-molar region
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of treatment
Number of subjects: 30
Study: 25682798

Group type: EXPERIMENTAL
Intervention: EHFP + MNP
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: EHFP
Number of subjects: 335

Group type: COMPARATOR
Intervention: Control
Number of subjects: 335
Study: 23866979

Group type: EXPERIMENTAL
Intervention: dKC-50 (50% replacement of SBM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: dKC-75 (75% replacement of SBM)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (0% replacement of SBM)
Number of subjects: 18
Study: 21574446

Group type: EXPERIMENTAL
Intervention: Cytoflavin as a component of combined therapy
Number of subjects: 50
Study: 19801054

Group type: EXPERIMENTAL
Intervention: Hydrophilic catheters
Number of subjects: 56

Group type: COMPARATOR
Intervention: Noncoated catheters (Control)
Number of subjects: 56
Study: 16952987

Group type: EXPERIMENTAL
Intervention: Anti-TNF-alpha therapy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 77
Study: 15242435

Group type: EXPERIMENTAL
Intervention: A-line AEP Monitor (AAI)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: End-expiratory sevoflurane concentration
Number of subjects: 112
Study: 11275039

Group type: EXPERIMENTAL
Intervention: Interferon beta (3 million IU daily for 5 days, followed by 2 days of rest for 3 weeks)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 9467221

Group type: EXPERIMENTAL
Intervention: High P/S diet (P/S ratio of 1.67)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Low P/S diet (P/S ratio of 0.19)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: High P/S ratio breakfast
Number of subjects: 6
Study: 8292640

Group type: EXPERIMENTAL
Intervention: Experimental condition: one monthly non‐random urine screen, one monthly counseling session, one monthly doctor visit, two times per month methadone pick up, a quarterly true random urine screen and participation in a diversion control program
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control condition: staying under standard conditions for six months and then being transferred to the experimental condition for six months
Number of subjects: 130
Study: 2949920

Group type: EXPERIMENTAL
Intervention: Human ultralente insulin (0.30 U/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Porcine ultralente insulin (0.30 U/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bovine ultralente insulin (0.30 U/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diluent (control)
Number of subjects: 6
Study: 29468229

Group type: EXPERIMENTAL
Intervention: Inletting energy of 7.5 eV
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Inletting energy of 9 eV
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Inletting energy of 12 eV
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Inletting energy of 15 eV
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Inletting energy range
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Minimum required inletting energy
Number of subjects: 2000
Study: 27507134

Group type: EXPERIMENTAL
Intervention: Guided e-learning intervention for managers
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Qualitative research alongside the trial
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Qualitative data
Number of subjects: 36
Study: 25304725

Group type: EXPERIMENTAL
Intervention: Valsartan (angiotensin receptor blocker)
Number of subjects: 3014

Group type: COMPARATOR
Intervention: Amlodipine (calcium channel blocker)
Number of subjects: 3014
Study: 21432861

Group type: EXPERIMENTAL
Intervention: Cobactin® (cyproheptadine + cobamamide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cobavital® (cyproheptadine + cobamamide)
Number of subjects: 0
Study: 19425895

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA) for asymptomatic stenosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA) for symptomatic stenosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 0
Study: 17559152

Group type: EXPERIMENTAL
Intervention: PEGIFN alpha‐2b + WBR 13.3 mg/kg/day + EPO 40,000 U/week
Number of subjects: 150

Group type: COMPARATOR
Intervention: PEGIFN alpha‐2b + WBR 13.3 mg/kg/day
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: PEGIFN alpha‐2b + higher dose WBR 15.2 mg/kg/day + EPO
Number of subjects: 150
Study: 15039008

Group type: EXPERIMENTAL
Intervention: SCP training (25 sessions within 3 weeks)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: SCP training
Number of subjects: 13

Group type: COMPARATOR
Intervention: Waiting-list group (Control)
Number of subjects: 13
Study: 11678553

Group type: EXPERIMENTAL
Intervention: Single flexible sigmoidoscopy (FS) at around the age of 60 with removal of all small adenomas during FS and colonoscopy for 'high risk' polyps.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not applicable.
Number of subjects: 0
Study: 9596245

Group type: EXPERIMENTAL
Intervention: Neuromuscular stimulation
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 46
Study: 8150838

Group type: EXPERIMENTAL
Intervention: Fibrin glue with thrombin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo with thrombin
Number of subjects: 10
Study: 3046385

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 7273929

Group type: EXPERIMENTAL
Intervention: Electrostimulation test
Number of subjects: 100

Group type: COMPARATOR
Intervention: No electrostimulation test (Control)
Number of subjects: 100
Study: 30412416

Group type: EXPERIMENTAL
Intervention: 2-3 week follow-up
Number of subjects: 344

Group type: COMPARATOR
Intervention: 6-8 week follow-up
Number of subjects: 344
Study: 28939589

Group type: EXPERIMENTAL
Intervention: Obesity (regardless of metabolic health)
Number of subjects: 21000

Group type: EXPERIMENTAL
Intervention: Obese and metabolically unhealthy
Number of subjects: 21000

Group type: EXPERIMENTAL
Intervention: Women who had never used hormone therapy
Number of subjects: 21000
Study: 25386711

Group type: EXPERIMENTAL
Intervention: Intravenous iron treatment (500 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 15
Study: 23320499

Group type: EXPERIMENTAL
Intervention: Constipation-related symptoms assessment using the Knowles-Eccersley-Scott Symptom questionnaire
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in anorectal angle and perineum descent during straining
Number of subjects: 0
Study: 21183857

Group type: EXPERIMENTAL
Intervention: Intravenous mannitol
Number of subjects: 60
Study: 19583049

Group type: EXPERIMENTAL
Intervention: Delayed weighing on day 5
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard care weighing on day 2 or 3
Number of subjects: 49
Study: 17578353

Group type: EXPERIMENTAL
Intervention: Fetal intrauterine resuscitation using tocolysis and delayed delivery
Number of subjects: 390

Group type: COMPARATOR
Intervention: Emergency delivery
Number of subjects: 390
Study: 21213490

Group type: EXPERIMENTAL
Intervention: 800 microg intravaginal misoprostol
Number of subjects: 50

Group type: COMPARATOR
Intervention: 400 microg intravaginal misoprostol
Number of subjects: 50
Study: 11784431

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) therapy
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (Fansidar) as replacement therapy
Number of subjects: 291
Study: 9569340

Group type: EXPERIMENTAL
Intervention: Blinded re-scrutiny of screening mammograms by two outside radiologists
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Interval cancers
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Screening programme design
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Age influence on interval cancer occurrence
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Criteria for referral for further investigation
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Efforts to reduce interval cancers
Number of subjects: 544
Study: 8038847

Group type: EXPERIMENTAL
Intervention: Oxygen insufflation during endotracheal suctioning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyperoxygenation protocol via ventilator
Number of subjects: 0
Study: 2494397

Group type: EXPERIMENTAL
Intervention: Computer-generated message reminding the doctor to check blood pressure
Number of subjects: 8298

Group type: EXPERIMENTAL
Intervention: Nurse contacted patients by telephone
Number of subjects: 8298

Group type: EXPERIMENTAL
Intervention: Sending a letter to patients
Number of subjects: 8298

Group type: COMPARATOR
Intervention: Normal-care control group
Number of subjects: 8298
Study: 56146

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES) 500 ml during surgery and on the following three days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isotonic saline solution 500 ml during surgery and on the following three days
Number of subjects: 10
Study: 31515821

Group type: EXPERIMENTAL
Intervention: Images taken by experienced cytologist
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Images taken by inexperienced cytologist
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Evaluation of five images
Number of subjects: 50

Group type: COMPARATOR
Intervention: Evaluation of two images
Number of subjects: 50
Study: 28291842

Group type: EXPERIMENTAL
Intervention: Opioid remifentanil (0.15 μg/kg/min) administered intravenously for 60 minutes
Number of subjects: 14

Group type: COMPARATOR
Intervention: Blindfolded condition
Number of subjects: 14

Group type: COMPARATOR
Intervention: Eyes-open condition
Number of subjects: 14
Study: 25874637

Group type: EXPERIMENTAL
Intervention: Dual-task training (n=8), performed cognitive tasks simultaneously with balance training.
Number of subjects: 15

Group type: COMPARATOR
Intervention: Single-task training (n=7), received balance training only.
Number of subjects: 15
Study: 23065659

Group type: EXPERIMENTAL
Intervention: Acute resistance exercise (3 sets, 10 repetitions at 60% 1RM)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control session (30-min seated rest)
Number of subjects: 13
Study: 21305572

Group type: EXPERIMENTAL
Intervention: Ultrasound examination of the sural nerve
Number of subjects: 100
Study: 20027552

Group type: EXPERIMENTAL
Intervention: Sterile water
Number of subjects: 44

Group type: COMPARATOR
Intervention: Isotonic saline solution
Number of subjects: 44
Study: 17172773

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Crack information control condition
Number of subjects: 29
Study: 15126714

Group type: EXPERIMENTAL
Intervention: 0.3 g x kg NaHCO3
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0.207 g x kg NaCl (CON)
Number of subjects: 10
Study: 11547222

Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 64

Group type: COMPARATOR
Intervention: Regular human insulin
Number of subjects: 64
Study: 9989324

Group type: EXPERIMENTAL
Intervention: Motivationally‐matched, individually‐tailored intervention (IT)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Standard self‐help intervention (ST)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 194
Study: 8160720

Group type: EXPERIMENTAL
Intervention: Psyllium fiber (6.7 g daily)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wheat bran control cereals
Number of subjects: 42
Study: 2895801

Group type: EXPERIMENTAL
Intervention: FEC (fluorouracil, cyclophosphamide, epirubicin)
Number of subjects: 263

Group type: COMPARATOR
Intervention: FAC (fluorouracil, cyclophosphamide, doxorubicin)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: FEC
Number of subjects: 263

Group type: COMPARATOR
Intervention: FAC
Number of subjects: 263
Study: 31892263

Group type: EXPERIMENTAL
Intervention: Comprehensive health-care program (CHCP) including open lectures, health counseling, exercise classes, nutrition counseling, and self-help group meetings
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Comprehensive health-care program (CHCP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 58
Study: 29948956

Group type: EXPERIMENTAL
Intervention: Pyridoxine (60 mg per day)
Number of subjects: 135

Group type: COMPARATOR
Intervention: No pyridoxine
Number of subjects: 135
Study: 28920767

Group type: EXPERIMENTAL
Intervention: Verum group (electroacupuncture device)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (sham device)
Number of subjects: 40
Study: 25099395

Group type: EXPERIMENTAL
Intervention: Direct EMG control
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pattern recognition control
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Starting from a predefined neutral posture
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Starting from the previous posture in the sequence
Number of subjects: 6
Study: 24490369

Group type: EXPERIMENTAL
Intervention: Conventional nursing plus health education, psychological counseling, and diet guidance (Experimental Group)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Conventional nursing (Control Group)
Number of subjects: 226
Study: 21360490

Group type: EXPERIMENTAL
Intervention: Tocilizumab 8 mg/kg plus MTX
Number of subjects: 1196

Group type: EXPERIMENTAL
Intervention: Tocilizumab 4 mg/kg plus MTX
Number of subjects: 1196

Group type: COMPARATOR
Intervention: Placebo plus MTX
Number of subjects: 1196
Study: 18471512

Group type: EXPERIMENTAL
Intervention: Terlipressin (1-2 mg/4 hour, intravenously) and albumin (1 g/kg followed by 20-40 g/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Albumin alone
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Terlipressin and albumin
Number of subjects: 46
Study: 17506795

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 0
Study: 12921475

Group type: EXPERIMENTAL
Intervention: SLI381 (Adderall XR) 10 mg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: SLI381 (Adderall XR) 20 mg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: SLI381 (Adderall XR) 30 mg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Adderall 10 mg (active control)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 11036846

Group type: EXPERIMENTAL
Intervention: Pool exercise combined with a 6 session education program
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 58
Study: 9044877

Group type: EXPERIMENTAL
Intervention: 123I-MIBG
Number of subjects: 8

Group type: COMPARATOR
Intervention: Propranolol (80 mg and 160 mg)
Number of subjects: 8
Study: 8239971

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 3899554

Group type: EXPERIMENTAL
Intervention: Postprandial exercise preceded by the usual dose of insulin
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Postprandial exercise preceded by one-half of the usual dose of insulin
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Postprandial exercise preceded by two-thirds of the usual dose of insulin
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Postprandial exercise without the usual dose of insulin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Resting control day
Number of subjects: 13
Study: 29570607

Group type: EXPERIMENTAL
Intervention: 1% chocolate milk (224 kcal)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: cola (158 kcal)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: fruit drink (154 kcal)
Number of subjects: 28

Group type: COMPARATOR
Intervention: water (control; 0 kcal)
Number of subjects: 28
Study: 25640037

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 24

Group type: COMPARATOR
Intervention: PLACEBO
Number of subjects: 24